Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-03

Clinical Trial Update: Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms [EARLY_Phase 1]

View source ↗

Summary

An EARLY Phase 1 trial is investigating whether tart cherry and omega-3 fatty acids can alleviate aromatase inhibitor-associated musculoskeletal symptoms (AIMSS…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 fatty acids (omega-3 fatty acids)
  • Tart Cherry

Snippet

Sponsor: Philip Chang | Conditions: Breast Cancer, Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) | EARLY_Phase 1 | Status: RECRUITING